Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 6,075 | 11,565 | 15,066 | 23,324 | 20,600 |
| Operating Income | -6,075 | -11,565 | -15,066 | -23,324 | -20,600 |
| Interest Expense | 13 | 13 | 13 | 12 | 13 |
| Other Income | 538 | 418 | 437 | 2,185 | 933 |
| Pre-tax Income | -5,550 | -11,160 | -14,642 | -21,151 | -19,680 |
| Income Tax | -16 | -57 | -71 | -25 | -22 |
| Net Income Continuous | -5,534 | -11,103 | -14,571 | -21,126 | -19,658 |
| Minority Interests | -3 | -13 | -5 | -2 | -10 |
| Net Income | $-5,531 | $-11,090 | $-14,566 | $-21,124 | $-19,648 |
| EPS Basic Total Ops | -0.14 | -0.27 | -0.36 | -0.52 | -0.49 |
| EPS Basic Continuous Ops | -0.14 | -0.27 | -0.36 | -0.52 | -0.49 |
| EPS Diluted Total Ops | -0.14 | -0.27 | -0.36 | -0.52 | -0.49 |
| EPS Diluted Continuous Ops | -0.14 | -0.27 | -0.36 | -0.52 | -0.49 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.27 | -0.36 | -0.52 | -0.49 |
| EBITDA(a) | $-5,219 | $-10,656 | $-14,165 | $-21,323 | $-18,566 |